Royal Philips, the global health technology leader, has announced its decision to sell its Emergency Care business to Bridgefield Capital, a US-based investment firm. This move aligns with Philips’ strategy to focus resources on areas that promise the greatest growth and financial impact.
The Emergency Care business, part of Philips’ Connected Care segment, provides critical products for acute care management both inside and outside of hospitals. This includes life-saving devices such as automated external defibrillators (AEDs) and other emergency care equipment for both professionals and consumers.
As part of the deal, Philips will enter into a 15-year exclusive brand license agreement, allowing Bridgefield Capital to manufacture, sell, and market Emergency Care products globally under the Philips brand.
This transaction is expected to close in the second half of 2025, pending regulatory approval and other conditions. Financial terms of the deal have not been disclosed.
This move comes after Philips outlined its renewed strategy in January 2023, focusing on high-growth areas in health technology. The company aims to allocate resources more efficiently to maximize its impact across key business segments.
Philips continues to innovate in health technology, providing advanced solutions for both consumers and healthcare professionals worldwide. The company’s portfolio includes diagnostic imaging, ultrasound, monitoring systems, and more, with a focus on improving health and well-being.
For more updates, visit Philips News Center.
If you have any questions or need assistance, feel free to reach out to us at MedSource Southwest. We’re here to support you every step of the way!
Stay tuned for more updates and resources to help you.